You are here: Industry Insights > Endo

News List

Endo enters settlement agreement to resolve opioid claims in Texas The payment as part of the deal will be made into the Texas State Qualified Settlement Fund.
December 27, 2021
Endo International and subsidiaries have signed a state-wide agreement to pay a total of $63m to settle claims linked to opioids in Texas state of the US.
Endo Begins Shipment of Generic MIACALCIN® Injection AmericanPharmaceuticalReview
November 19, 2021
Endo International plc announced that its Par Sterile Products business has begun shipping calcitonin salmon injection, USP, multi-dose vials (2 mL) following final approval from the FDA for its Abbreviated New Drug Application.
Strides Pharma Science to acquire Endo’s manufacturing facility in US expresspharma
August 09, 2021
Strides said the facility at Chestnut Ridge, New York has an annual capacity of two billion units across semi-solids, liquids and nasal sprays, along with oral solids.
Endo agrees opioid settlement payment with Oklahoma for $8.75m europeanpharmaceuticalreview
January 15, 2020
The US state of Oklahoma has agreed to a settlement from Endo International after an investigation into its role in the opioid abuse crisis.
Endo and Allergan settle opioid case ahead of trial europeanpharmaceuticalreview
September 04, 2019
The two pharma companies have agreed to pay $15 million to certain Ohio counties before an opioid abuse trial to be held in October.
Endo strikes $10M opioid settlement with just 2 Ohio counties, and Allergan may not be far behind fiercepharma
August 22, 2019
As the closely-watched opioid litigation in Ohio nears its first trial, Endo has struck a $10 million settlement and Allergan is said to be nearing its own deal.
Endo Announces Executive VP, Chief Commercial Officer Appointment americanpharmaceuticalreview
August 02, 2019
Endo announced the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately.
Endo Appoints EVP and CCO, Sterile and Generics contractpharma
August 02, 2019
Ciarico to lead commercial strategy and execution for Endo's Generics Pharmaceutical and Sterile Injectable businesses.
$70 Million Settlement Reached in Generic Drug Delay Case drugs
July 31, 2019
Three drug companies will pay a total of nearly $70 million to California to settle charges of delaying the sale of generic drugs to keep brand-name drug prices high...
Endo CEO Campanelli nabs almost $20M in 2018 pay, thanks to special 2017 bonus fiercepharma
May 06, 2019
Endo’s stock price hasn’t at all recovered from a sharp decline thanks to generics price erosion and a gloomy outlook for the company’s business. But CEO Paul Campanelli snagged a huge pay pump in 2018 anyway—and not just because the board thinks he's don

Previous page 1 2 3 Next page